Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7450 p525
5 May 2007

This article
Reprint   Photocopy

PDF 50K, Acrobat Reader

Letters

• White Paper (4)
• MURs (2)
• Dispensing errors
• Chemotherapy
• Medication review
• Pfizer
• Locum pharmacy


Letters to the Editor

Pfizer

A word of warning

From Mr P. R. Rodwell, MRPharmS

A word of warning to your readers: find out your Pfizer credit limit. If pharmacists overspend their limit Pfizer will put their accounts on hold without warning.

This happened to me over Easter while I was away and could not be resolved for the best part of 10 days. Fortunately UniChem (my primary wholesaler) was able to find a solution of sorts. Cash flow and funds are not an issue.

As for Pfizer, it did not want to know. It does have a monopoly I suppose.

Paul Rodwell
Wallingford, Oxfordshire

 

DAVID WATSON, head of trade at Pfizer, responds:

Pfizer’s new distribution arrangement has been designed to be as simple and straightforward as possible. We have a responsibility to make sure that our prescription medicines are being distributed in the correct manner and sold according to our terms and conditions. As part of the development of our new arrangement, we will do our best to notify customers directly in the event of there being any credit issues. These scenarios are rare. If we think there is a legitimate reason to put an account on hold, we will aim to resolve the issue and reinstate the account as quickly as possible. We are committed to ensuring the best possible service to our customers.

Pharmacists who would like to speak to Pfizer about any aspect of the service can call the Pfizer team on 0845 6088866.

Send your letter to The Editor

Previous Topic (Medication review)
Next Topic (Locum pharmacy)

Back to Top


©The Pharmaceutical Journal